Seattle, WA – Advance Sandblast- Seattle Portable Sandblasting Service offers dependable, on-site sandblasting solutions to help property owners clean and restore exterior surfaces. Whether it’s removing layers of paint, stripping rust, or eliminating built-up grime, the company’s services are tailored to meet the needs of both residential and commercial clients. These eco-friendly solutions are ideal […]

Stockton, CA – Knights Plumbing & Drain offers a service designed for homeowners planning kitchen and bathroom upgrades. The company is now providing full-service sink and fixture installations throughout Stockton, CA, allowing residents to streamline home renovation tasks and reduce their water usage through modern fixture replacements. With an increasing number of homeowners opting to

A groundbreaking new study, published in PLOS One, has uncovered key behavioural factors influencing how medications are prescribed to people living with neurodegenerative diseases. The findings raise important questions about clinical decision-making, and the need for more targeted strategies in managing complex neurological conditions, including Parkinson's Disease. https://mma.prnewswire.com/media/2719901/Alpharmaxim_brain.jpg Conducted by Alpharmaxim and Aston University, Birmingham

Bizcap, a leading provider of fast and flexible business loans, has announced its launch into Luxembourg, establishing its first operational footprint in continental Europe. The move signals Bizcap's commitment to empowering small and medium-sized enterprises (SMEs) across the globe with fast, flexible, and transparent financing. Founded in Australia, Bizcap has established itself across Australia and

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team Egham, UK – 03 July 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Simon Ramsden as Chief Financial Officer and Rob Smith as

Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics' proprietary OGAP(R)-Verify discovery platform OBT receives milestone payment associated with advance of drug candidate Oxford, UK and San Jose, California, 3 July 2025 – Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO)

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team GlobeNewswire July 03, 2025 Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team Egham, UK – 03 July 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients

Oxford BioTherapeutics Announces Third Oncology Drug Candidate from Boehringer Ingelheim Collaboration Selected to Advance into IND-Enabling Studies GlobeNewswire July 03, 2025 Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics' proprietary OGAP(R)-Verify discovery platform OBT receives milestone payment associated with advance of drug candidate Oxford, UK and

Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 and Nectin4. AK146D1 is Akeso's first bispecific ADC to enter clinical trials. AK146D1 has recently received approval from the U.S. FDA, Australia's TGA, and

The Volvo Group report for the second quarter 2025 will be published on July 17, at 7.20 a.m.CEST. There will be a conference call for press and analysts starting at 9.00 a.m. CEST. An online presentation of the report, followed by a question-and-answer session, will be broadcasted at 9.00 a.m. CEST. The Volvo Group will